Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Paraneoplastic Raynaud’s phenomenon as an initial manifestation of lung cancer?.Eur J Case Rep Intern Med. 2021; 8002690
- Late-onset immunotherapy toxicity and delayed autoantibody changes: checkpoint inhibitor-induced Raynaud’s-like phenomenon.Oncologist. 2020; 25: e753-e757
- Immunoglobulins to mitigate paraneoplastic Lambert Eaton myasthenic syndrome under checkpoint inhibition in Merkel cell carcinoma.Neurol Res Pract. 2020; 2: 52
- Paraneoplastic Raynaud’s phenomenon--good palliation after a multidisciplinary approach.J Pain Symptom Manag. 2010; 39: 779-783
Disclosure: The authors declare no conflict of interest.